论文部分内容阅读
第1期:A;A、B;B;D;A、E;C;D;E;E;C第3期:B;A、E;E;缺血预处理;心血管;靶分子;植物雌激素;注射液;进行比较;避免发生第5期:C;E;E;A;E;改性;亲脂性;减少钙;消化道;根除第7期:多晶型现象;溶解度,溶出速率,体内吸收;基因多态性;仿垂体;吉非替尼;生物学数据;纤维蛋白原;诱导,抑制;预防;近30%第9期:外排;相互作用;P-gp;不同性别;差异大;溶解性;第一责任;较高,较高;长,弱,少;我国第11期:质量源于设计;分泌,进入;光活性;最初,最轻;布洛芬,吲哚美辛;降低;减少,增加;肥胖,糖尿病;信号转移;计划、实施、检查、处理
Phase 1: A; A; B; B; D; A, E; C; D; E; E; C Phase 3: B; A, E; E; Ischemic Preconditioning; Cardiovascular; Target Molecules; Phytoestrogen; Injection; Comparisons; Avoidance of Occurrence Phase 5: C; E; E; A; E; Modification; Lipophilicity; Reduction of Calcium; Digestive Tract; Eradication Stage 7: Polymorphism; Solubility, Dissolution rate, absorption in vivo; gene polymorphism; pituitary; gefitinib; biological data; fibrinogen; induction, inhibition; prevention; nearly 30% No.9: efflux; interaction; P-gp; Different sex, big difference, solubility, first responsibility, higher, higher, longer, weaker, less China's No.11: Quality originates from design, secretion, entry, light activity, initial and lightest, ibuprofen , Indomethacin; decrease; decrease, increase; obesity, diabetes; signal transfer; plan, implement, check, deal with